"Die Fachklinik Hornheide ist ein interdisziplinäres und überregionales Zentrum für die Behandlung von Tumoren der Haut, des Kopf-Hals-Bereichs sowie chirurgischer Rekonstruktion."

During the past decade, Fachklinik Hornheide conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fachklinik Hornheide" #1 sponsor was "Prof. Dr. med. Dirk Schadendorf" with 3 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "CureVac" with 1 trials sponsored and "EuMelaReg gGmbH" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fachklinik Hornheide" #1 collaborator was "Alcedis GmbH" with 1 trials as a collaborator, "BioNTech SE" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Cromos Pharma LLC" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Fachklinik Hornheide" are "Melanoma" (4 trials), "Malignant Melanoma" (2 trials), "Melanoma (Skin)" (2 trials), "Advanced Melanoma" (1 trials) and "Basal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Fachklinik Hornheide" in a lesser frequency.

Most popular intervention types in "Fachklinik Hornheide" are "Drug" (10 trials), "Biological" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Pembrolizumab" (2 trials), "Placebo" (2 trials), "Vemurafenib" (2 trials), "Bempegaldesleukin" (1 trials) and "Binimetinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fachklinik Hornheide" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Fachklinik Hornheide". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Fachklinik Hornheide, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Fachklinik Hornheide, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Fachklinik Hornheide has several departments that took part in Clinical trials: "Fachklinik Hornheide; Dermatologie" - 3 trials, "Fachklinik Hornheide - Internistische Onkologie" - 2 trials